Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

WHO-led consensus statement on vaccine delivery costing: process, methods, and findings.
Levin, A; Boonstoppel, L; Brenzel, L; Griffiths, U; Hutubessy, R; JIT, M; Mogasale, V; Pallas, S; Resch, S; Suharlim, C; Yeung, KH T;
2022
BMC MEDICINE, (2022).20 1 10.1186/s12916-022-02278-4.
"We don't have the same bodies; we don't react the same way": mothers and adolescent girls' perceptions of the risks and benefits of HPV vaccination in France.
KARAFILLAKIS, E; Peretti-Watel, P; Verger, P; CHANTLER, T; LARSON, HJ;
2022
HUMAN VACCINES & IMMUNOTHERAPEUTICS, (2022).18 1 10.1080/21645515.2022.2036555.
Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study.
Debellut, F; Pecenka, C; Hausdorff, WP; CLARK, A;
2022
Human vaccines & immunotherapeutics, (2022).18 1 10.1080/21645515.2022.2040329.
Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China.
Weerasuriya, CK; Harris, RC; MCQUAID, CF; BOZZANI, F; Ruan, Y; Li, R; Li, T; Rade, K; Rao, R; Ginsberg, AM; Gomez, GB; WHITE, RG;
2022
BMC medicine, (2022).20 1 10.1186/s12916-022-02306-3.
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
Feikin, DR; Higdon, MM; Abu-Raddad, LJ; Andrews, N; Araos, R; Goldberg, Y; Groome, MJ; Huppert, A; O'Brien, KL; SMITH, PG; WILDER-SMITH, A; Zeger, S; Deloria Knoll, M; Patel, MK;
2022
Lancet, (2022).399 10328 10.1016/S0140-6736(22)00152-0.
T-Cell Responses after Rotavirus Infection or Vaccination in Children: A Systematic Review.
LABAN, NM; GOODIER, MR; Bosomprah, S; Simuyandi, M; Chisenga, C; Chilyabanyama, ON; Chilengi, R;
2022
VIRUSES-BASEL, (2022).14 3 10.3390/v14030459.
Impact of seasonal RTS,S/AS01E vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and Mali.
GRANT, J; Sagara, I; Zongo, I; CAIRNS, M; Yerbanga, RS; Diarra, M; Zoungrana, C; Issiaka, D; Nikièma, F; Sompougdou, F; Tapily, A; Kaya, M; Haro, A; Sanogo, K; Sienou, AA; Traore, S; Thera, I; Yalcouye, H; Kuepfer, I; SNELL, P; MILLIGAN, P; Ockenhouse, C; Ofori-Anyinam, O; Tinto, H; Djimde, A; ... Ouédraogo, J-B.
2022
Malaria Journal, (2022).21 1 10.1186/s12936-022-04077-x.
Evolving measles status and immunization policy development in six European countries.
Vojtek, I; LARSON, H; Plotkin, S; Van Damme, P;
2022
Human vaccines & immunotherapeutics, (2022).18 1 10.1080/21645515.2022.2031776.
Localising vaccination services: Qualitative insights on public health and minority group collaborations to co-deliver coronavirus vaccines.
Kasstan, B; MOUNIER-JACK, S; Letley, L; GASKELL, KM; ROBERTS, CH; Stone, NR H; LAL, S; EGGO, RM; MARKS, M; CHANTLER, T;
2022
Vaccine, (2022).40 14 10.1016/j.vaccine.2022.02.056.
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.
Sparrow, E; ADETIFA, I; Chaiyakunapruk, N; Cherian, T; Fell, DB; Graham, BS; Innis, B; Kaslow, DC; Karron, RA; Nair, H; Neuzil, KM; Saha, S; SMITH, PG; Srikantiah, P; Were, F; Zar, HJ; Feikin, D;
2022
Vaccine, (2022).40 26 10.1016/j.vaccine.2022.02.040.